Fosun Pharma
| Formerly |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Company type | listed | ||||||||||
| Industry |
| ||||||||||
| Founded | 1994 | ||||||||||
| Founder |
| ||||||||||
| Headquarters | Shanghai , China | ||||||||||
Key people |
| ||||||||||
| Services | private hospitals | ||||||||||
| CN¥3.125 billion (2017) | |||||||||||
| Total assets | CN¥61.914 billion (2017) | ||||||||||
| Total equity | CN¥25.270 billion (2017) | ||||||||||
| Owner | Fosun Int'l (37.94%) | ||||||||||
| Subsidiaries |
| ||||||||||
| Chinese name | |||||||||||
| Simplified Chinese | 上海复星医药（集团）股份有限公司 | ||||||||||
| Traditional Chinese | 上海復星醫藥（集團）股份有限公司 | ||||||||||
| |||||||||||
| Chinese short name | |||||||||||
| Simplified Chinese | 复星医药 | ||||||||||
| Traditional Chinese | 復星醫藥 | ||||||||||
| |||||||||||
| former Chinese short name | |||||||||||
| Simplified Chinese | 复星实业 | ||||||||||
| Traditional Chinese | 復星實業 | ||||||||||
| |||||||||||
| Website | www | ||||||||||
| Footnotes / references in consolidated financial statement | |||||||||||
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (trade name: Fosun Pharma) is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world.